Addressing a Rozgar Mela where he distributed over 51,000 appointment letters to the youth, mostly in the security forces, the prime minister said automobile, pharma, tourism and food processing sectors were expected to grow...
Drugmaker Cipla’s shares hit a fresh 52-week high on the BSE after reports that Blackstone is likely to acquire the entire 33.47 per cent promoter stake in the pharma major
The SPC pharma company filed its draft papers with the markets regulator in March seeking its nod, obtained its observations letter on June 30, an update with the Securities and Exchange Board of India (Sebi) showed on...
Total expenses were higher at Rs 660.2 crore as compared to Rs 533.1 crore a year ago
Icra said that a continued focus on complex generics/speciality launches in the US market is expected to support industry margins in FY2024
The companies have come together to commercialise Philogen's speciality product Nidlegy, an anti-cancer biopharmaceutical currently in Phase III clinical trials, Sun Pharma said in a statement
The open-ended thematic fund will invest in a diversified portfolio of companies across themes, such as fintech, specialty chemicals and pharma, auto and auto ancillaries, and Internet-based businesses, among others. The new...
Hari S Bhartia has decided to step down from the position of Managing Director of the company effective closing business hours of May 31
JB Pharma's revenue of the company stood at Rs 762 crore in the fourth quarter of FY23 as against Rs 625 crore in the same period of FY22
Director General Foreign Trade (DGFT) Santosh Kumar Sarangi said all pharmaceutical products must meet global standards and quality requirements
The agreement between Glenmark Pharmaceuticals Inc USA and Cediprof Inc, covers supply and distribution agreement for Cediprof's FDA-approved medicines
The acquisition will complement Dr Reddy's US retail prescription pharmaceutical business with limited competition products
More than 30,000 new cases of BTC are seen in India every year with 90 per cent of them diagnosed in the advanced stage
As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride...
Piramal Pharma on Thursday reported a net loss of Rs 90 crore on a consolidated basis for the third quarter ended December 31, 2022.
Nirmala Sitharaman also said facilities in select ICMR (Indian Council of Medical Research) labs will be made available for research by public and private...
Four cough syrups manufactured by the said pharma has allegedly led to death of 66 children in the Gambia, following which the World Health Organisation (WHO)...
The Commissioner For Entrance Examinations, Government of Kerala is expected to release its KEAM Result 2022 on the official website on July 25th, 2022. The...
Prashant Jain, the executive director and CIO of HDFC AMC shared his views on the ongoing stock market correction, the underlying opportunities, and how he...
Prime Minister Narendra Modi will also be addressing a public function at Paraunkh village in Kanpur and visiting Pathri Mata Mandir with...
Zydus said it has received approval from the US Food and Drug Administration, which allows for a site transfer and manufacturing of the drug at Jarod.
The Mumbai-based drugmaker has launched the product in the US market under an exclusive license, marketing, and distribution agreement with Slayback Pharma LLC
The acquisition will strengthen the company's India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements, and...
Comes in wake of Sebi’s guidelines to bring in uniformity in benchmark of mutual fund schemes
The approval by the USFDA is for the abbreviated new drug application (ANDA) for Lacosamide Tablets of strengths 50 mg, 100 mg, 150mg, and 200 mg.
